Skip to content

Seelos Therapeutics, Inc.: filings

Every Seelos Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 53 filings, each linked to its SEC index.

Filing record ends 2024-08-14

The latest filing in this captured record is a 10-Q filed 2024-08-14. No later filing is in the SEC companyfacts record captured on 2026-09-22. Seelos Therapeutics, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-08-14fiscal Q2 2024351030001410578-24-001435
10-Q2024-05-14fiscal Q1 202434690001410578-24-000773
10-K2024-03-06fiscal FY 202334660001410578-24-000140
10-Q2023-11-14fiscal Q3 2023351020001410578-23-002472
10-Q2023-08-11fiscal Q2 202334970001410578-23-001773
10-Q2023-05-12fiscal Q1 202333670001104659-23-059713
10-K2023-03-10fiscal FY 202232630001104659-23-030733
10-Q2022-11-10fiscal Q3 202232950001136261-22-000332
10-Q2022-08-05fiscal Q2 202232960001136261-22-000286
10-Q2022-05-10fiscal Q1 202231640001136261-22-000210
10-K2022-03-04fiscal FY 202127540001136261-22-000156
10-Q2021-11-05fiscal Q3 202126740001136261-21-000231
10-Q2021-08-06fiscal Q2 202126730001136261-21-000187
10-Q2021-04-30fiscal Q1 202123490001136261-21-000064
10-K2021-03-11fiscal FY 202024500001136261-21-000034
10-Q2020-11-12fiscal Q3 202022640001136261-20-000180
10-Q2020-08-14fiscal Q2 202021610001136261-20-000156
10-Q2020-05-07fiscal Q1 202021460001136261-20-000114
10-K2020-03-17fiscal FY 201924500001136261-20-000092
10-Q2019-11-07fiscal Q3 201923650001136261-19-000264
10-Q2019-08-01fiscal Q2 201921600001136261-19-000209
10-Q2019-05-21fiscal Q1 201921460001136261-19-000166
10-K2019-03-28fiscal FY 201832660001136261-19-000121
10-Q2018-10-31fiscal Q3 201828710001017491-18-000103
10-Q2018-08-09fiscal Q2 201824640001017491-18-000075
10-Q2018-05-03fiscal Q1 201823480001017491-18-000059
10-K2018-03-01fiscal FY 201730620001017491-18-000026
10-Q2017-11-02fiscal Q3 201725660001017491-17-000125
10-Q2017-08-02fiscal Q2 201725660001017491-17-000091
10-Q2017-05-11fiscal Q1 201729600001017491-17-000074
10-K2017-03-13fiscal FY 201638800001017491-17-000030
10-Q2016-11-08fiscal Q3 201634880001017491-16-000234
10-Q2016-08-04fiscal Q2 201634880001017491-16-000215
10-Q2016-05-09fiscal Q1 201639800001017491-16-000164
10-K2016-03-09fiscal FY 2015381180001017491-16-000112
10-Q2015-11-05fiscal Q3 201531800001017491-15-000083
10-Q2015-08-05fiscal Q2 201535960001017491-15-000069
10-Q2015-05-11fiscal Q1 201533680001017491-15-000054
10-K2015-03-16fiscal FY 2014411270001017491-15-000032
10-Q2014-11-10fiscal Q3 201431800001017491-14-000103
10-Q2014-08-11fiscal Q2 201434960001017491-14-000079
10-Q2014-05-12fiscal Q1 201431640001017491-14-000070
10-K2014-03-17fiscal FY 2013401190001017491-14-000052
10-Q2013-11-12fiscal Q3 201336960001017491-13-000005
10-Q2013-08-14fiscal Q2 201335900001193125-13-334791
10-Q2013-05-10fiscal Q1 201333680001193125-13-213296
10-K2013-03-18fiscal FY 2012391090001193125-13-111046
10-Q2012-11-08fiscal Q3 201238930001144204-12-060431
10-Q2012-08-09fiscal Q2 201235900001144204-12-044020
10-Q2012-05-10fiscal Q1 201235710001144204-12-027576
10-K2012-03-13fiscal FY 201137910001144204-12-014548
10-Q2011-11-14fiscal Q3 201128710001144204-11-063714
10-Q2011-08-15fiscal Q2 201128710001144204-11-046337

Inspect the source

Entity
Seelos Therapeutics, Inc. / CIK 0001017491
Captured
SEC response SHA-256
961ebd62701ef4cfd55c6e1214079957434cc9cd169cddd39498b16f5ee39f27

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001017491.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))